276 related articles for article (PubMed ID: 35078269)
1. Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease.
Bera A; Lavanya G; Reshmi R; Dev K; Kumar R
Eur J Neurosci; 2022 Nov; 56(9):5516-5531. PubMed ID: 35078269
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
3. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
[TBL] [Abstract][Full Text] [Related]
4. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.
Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J
J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841
[TBL] [Abstract][Full Text] [Related]
6. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
7. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
9. A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease.
Kandimalla R; Manczak M; Pradeepkiran JA; Morton H; Reddy PH
Hum Mol Genet; 2022 Jun; 31(11):1788-1805. PubMed ID: 34919689
[TBL] [Abstract][Full Text] [Related]
10. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
[TBL] [Abstract][Full Text] [Related]
11. Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.
Qi Z; Huang Z; Xie F; Chen L
J Cell Physiol; 2019 Jul; 234(7):10032-10046. PubMed ID: 30515821
[TBL] [Abstract][Full Text] [Related]
12. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
Manczak M; Calkins MJ; Reddy PH
Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
[TBL] [Abstract][Full Text] [Related]
13. The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster.
Abtahi SL; Masoudi R; Haddadi M
Gene; 2020 Sep; 754():144854. PubMed ID: 32525045
[TBL] [Abstract][Full Text] [Related]
14. Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells.
Park SJ; Bae JE; Jo DS; Kim JB; Park NY; Fang J; Jung YK; Jo DG; Cho DH
Mol Brain; 2021 Jan; 14(1):6. PubMed ID: 33422108
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease.
Dhapola R; Sarma P; Medhi B; Prakash A; Reddy DH
Mol Neurobiol; 2022 Jan; 59(1):535-555. PubMed ID: 34725778
[TBL] [Abstract][Full Text] [Related]
16. Role of proline-rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease.
Kumar R; Tiwari V; Dey S
Eur J Neurosci; 2022 Nov; 56(9):5442-5452. PubMed ID: 34905657
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
18. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
[TBL] [Abstract][Full Text] [Related]
19. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
20. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
